what percentage of americans are on glp 1 Big shift in U.S. health! A new Gallup poll shows 11% now taking GLP-1 drugs, coinciding with obesity rates dropping to 36.4% (down from 39.9% in 2022). Promising progress in New study reveals record number

-6% This marks the first head-to-head Phase 3 trial of a dual GLP-1/glucagon RA versus semaglutide a landmark step toward understanding how these emerging agents compare

For some individuals, the effects of a B12 injection may be more subtle or gradual, while for others, the effects may be more immediate and noticeable

If GLP-1s are going to move from metabolic medicine into the worlds of pain and substance use disorders, we should talk about them the way we would talk about any powerful new class: with evidence, not mythology

Novel insulin-elicited phosphoproteins in adipocytes

UAMS brings academic-level obesity research and fellowship-trained specialists to a market that desperately needs them

Popular peptides and antioxidants include Wolverine Protocol, glutathione, NAD+, and LL-37